SUMMARY OF HEPATITIS

Question 1

Serum hepatitis

Answer 1

HBV

Question 2

Post transfusion hepatitis

Answer 2

HCV

Question 3

Non A and Non B hepatitis

Answer 3

HCV

Question 4

Picornaviridae ssRNA

Answer 4

HAV

Question 5

Hepadnaviridae dsDNA

Answer 5

HBV

Question 6

Flaviviridae ssRNA

Answer 6

HCV

Question 7

Deta virus; requires HBV for replication

Answer 7

HDV

Question 8

Caliciviridae ssRNA

Answer 8

HEV

Question 9

15-45 days

Answer 9

HAV

Question 10

45-160 days

Answer 10

HBV

Question 11

15-150 days

Answer 11

HCV

Question 12

30-60 days

Answer 12

HDV

Question 13

15-60 days

Answer 13

HEV

Question 14

Fecal-oral

Answer 14

HAV
HEV

Question 15

Sex, blood transfusion, sharing of needles, transplacental saliva, breastmilk

Answer 15

HBV
HDV

Question 16

Sex, blood transfusion, sharing of needles, transplacental saliva, breastmilk, hemodialysis

Answer 16

HCV

Question 17

Infectious hepatitis

Answer 17

HAV

Question 18

• Present in stool and plasma for an average of 18 days after the clinical of disease

Answer 18

HAV RNA

Question 19

• Indicates recent infection

Answer 19

Anti-HAV IgM

Question 20

• Develops 2-3 weeks after ingestion and persists up to 3-6 mos

Answer 20

Anti-HAV IgM

Question 21

• Develops 1-2 weeks after IgM

Answer 21

Anti-HAV IgG

Question 22

• Present for life

Answer 22

Anti-HAV IgG

Question 23

• Active hepatitis B

Answer 23

HbsAg

Question 24

• Acute infection and infectivity

Answer 24

HbsAg

Question 25

• General marker of infection

Answer 25

HbsAg

Question 26

• Active hepatitis B with high degree with increased risk of infectivity

Answer 26

HBeAg

Question 27

• Circulating for HbcAg

Answer 27

HBeAg

Question 28

• Current or recent and hepatocellular acute hepatitis B

Answer 28

Anti-HBc IgM

Question 29

• Important in diagnosing during window period.

Answer 29

Anti-HBc IgM

Question 30

• Current or past hepatitis B

Answer 30

Total anti-HBc

Question 31

• Recovery from hepatitis B

Answer 31

Anti-HBe

Question 32

• Immunity to hepatitis B or past infection

Answer 32

Anti-HBs

Question 33

• Acute, atypical, or occult hepatitis B

Answer 33

HBV DNA

Question 34

• Viral load may be used to monitor effectiveness of therapy

Answer 34

HBV DNA

Question 35

• Generally used to diagnose Hepatitis C infection.

Answer 35

Anti-HCV

Question 36

• 4 weeks after infection (not reliable)

Answer 36

Anti-HCV

Question 37

• Used in monitoring he response to antiviral therapy

Answer 37

HCV-RNA

Question 38

• Diagnosis in the acute phase

Answer 38

HCV-RNA

Question 39

• Identification of HCV genotype

Answer 39

HCV-RNA

Question 40

increase risk infectivity Indicated that virus has high degree of infectivity

Answer 40

Envelope antigen

Question 41

Progression to chronic state

Answer 41

HBV HCV HDV

Question 42

No Progression to chronic state

Answer 42

HAV HEV

Question 43

Acute, self limiting

Answer 43

HAV HEV

Question 44

Most: acute

Answer 44

HBV

Question 45

Others: Chronic (10%-90%), cirrhosis, risk of Ca

Answer 45

HBV

Question 46

80-85% will have a chronic disease

Answer 46

HCV

Question 47

15-20% spontaneous resolution

Answer 47

HCV

Question 48

Super infection/ coninfection with Hepatitis B

Answer 48

HDV

Question 49

Acute selflimiting

Answer 49

HAV HEV

Question 50

Fluminant liver failure in pregnant women

Answer 50

HEV

Question 51

(+) Early infection

Answer 51

Anti-HBc IgM Total Anti-HBc HBeAg HBV DNA

Question 52

(-) Early infection

Answer 52

Anti-HBs Anti-HBe

Question 53

(+) Window

Answer 53

Anti-HBc IgM Total Anti-HBc HBV DNA

Question 54

(-) Window

Answer 54

HBeAg HBsAg Anti-HBs Anti-HBe

Question 55

(-) Convalescent

Question 56

(+) Convalescent

Question 57

(+/-) Convalescent

Question 58

(-/+) Convalescent

Question 59

(+/-) Chronic

Question 60

(-/+) Chronic

Question 61

(+) Chronic

Question 62

(-) Chronic

Question 63

(-) Post vaccination

Question 64

(+) Post vaccination